1 |
Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol 2003;119:497-504.
DOI
ScienceOn
|
2 |
Lubenow N, Selleng S, Wollert HG, Eichler P, Mullejans B, Greinacher A. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 2003;75:577-9.
DOI
ScienceOn
|
3 |
Martin ME, Kloecker GH, Laber DA. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol 2007;78: 161-6.
|
4 |
Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(3 Suppl):311S-7S.
|
5 |
Ban-Hoefen M, Francis C. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. Thromb Res 2009;124:189-92. Epub 2009 Feb 4.
DOI
ScienceOn
|
6 |
Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2:148-57.
|
7 |
Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender and hepatic or renal dysfunction. Pharmacotherapy 2000;20:318-29.
DOI
ScienceOn
|
8 |
Levine RL, Hursting MJ, David McCollum MS. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest 2006;129;1167-75.
DOI
ScienceOn
|